These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16531262)

  • 1. The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial.
    Cimino G; Pane F; Elia L; Finolezzi E; Fazi P; Annino L; Meloni G; Mancini M; Tedeschi A; Di Raimondo F; Specchia G; Fioritoni G; Leoni P; Cuneo A; Mecucci C; Saglio G; Mandelli F; Foà R;
    Haematologica; 2006 Mar; 91(3):377-80. PubMed ID: 16531262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
    Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute lymphoblastic leukemia with p190 type bcr/abl chimeric mRNA at relapse].
    Choi I; Matsushima T; Fujii T; Shiratsuchi M; Abe Y; Nishimura J; Nawata H; Muta K
    Rinsho Ketsueki; 2002 Sep; 43(9):836-40. PubMed ID: 12412288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of BCR/ABL isoforms in the presentations and outcome of Philadelphia-positive acute lymphoblastic leukemia in adult patients].
    Li YN; Zou DH; Gu M; Mi YC; Wang JX; Qiu LG
    Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):481-4. PubMed ID: 19954044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
    Juric D; Lacayo NJ; Ramsey MC; Racevskis J; Wiernik PH; Rowe JM; Goldstone AH; O'Dwyer PJ; Paietta E; Sikic BI
    J Clin Oncol; 2007 Apr; 25(11):1341-9. PubMed ID: 17312329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM; Kreisel FH; Zehnbauer BA; Kulkarni S; Hassan A; Frater JL
    Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR/ABL rearrangement with b3a3 fusion transcript in a case of childhood acute lymphoblastic leukemia.
    Kim J; Park TS; Lyu CJ; Song J; Lee KA; Kim SJ; Lee HJ; Choi JR
    Cancer Genet Cytogenet; 2009 Mar; 189(2):132-7. PubMed ID: 19215796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic characterization of a BCR-ABL transduced mouse cell line.
    Rudolph C; Hegazy AN; von Neuhoff N; Steinemann D; Schröck E; Stripecke R; Klein C; Schlegelberger B
    Cancer Genet Cytogenet; 2005 Aug; 161(1):51-6. PubMed ID: 16080957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of Clinical Outcomes between P190 and P210 Trans-cripts in Adult Ph Chromosome Positive Acute Lymphoblastic Leukemia in the New Era of TKI].
    Qiu LL; Lu YJ; Jing Y; Yu L; Liu DH; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):369-74. PubMed ID: 27150994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl.
    Hemmeryckx B; Reichert A; Watanabe M; Kaartinen V; de Jong R; Pattengale PK; Groffen J; Heisterkamp N
    Oncogene; 2002 May; 21(20):3225-31. PubMed ID: 12082638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia and survival in childhood acute lymphoblastic leukemia.
    Teuffel O; Stanulla M; Cario G; Ludwig WD; Rottgers S; Schafer BW; Zimmermann M; Schrappe M; Niggli FK
    Haematologica; 2008 Nov; 93(11):1652-7. PubMed ID: 18815194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.
    Gleissner B; Gökbuget N; Bartram CR; Janssen B; Rieder H; Janssen JW; Fonatsch C; Heyll A; Voliotis D; Beck J; Lipp T; Munzert G; Maurer J; Hoelzer D; Thiel E;
    Blood; 2002 Mar; 99(5):1536-43. PubMed ID: 11861265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to imatinib of bcr/abl p190 lymphoblastic leukemia cells.
    Mishra S; Zhang B; Cunnick JM; Heisterkamp N; Groffen J
    Cancer Res; 2006 May; 66(10):5387-93. PubMed ID: 16707466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
    Castor A; Nilsson L; Astrand-Grundström I; Buitenhuis M; Ramirez C; Anderson K; Strömbeck B; Garwicz S; Békássy AN; Schmiegelow K; Lausen B; Hokland P; Lehmann S; Juliusson G; Johansson B; Jacobsen SE
    Nat Med; 2005 Jun; 11(6):630-7. PubMed ID: 15908956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.